Drug Trial Radar · NCT07074886
A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)
Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
193
Actual
Start
Nov 13, 2025
Primary completion
Sep 17, 2026
Study completion Mar 31, 2030
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Jul 20, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to assess the bioequivalence of ocrelizumab SC test formulation to the marketed ocrelizumab SC reference formulation in participants with either relapsing multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS). The study consists of 2 phases: a controlled phase, where participants in each group will receive one dose of test or reference formulation and a continuation phase, where all participants in both groups will receive ocrelizumab SC test formulation.
Conditions
- Multiple Sclerosis
Interventions
Ocrelizumab Test FormulationDrug
Ocrelizumab test formulation will be administered as per the schedule specified in the respective arm.
Ocrelizumab Reference FormulationDrug
Ocrelizumab reference formulation will be administered as per the schedule specified in the respective arm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area Under the Serum Concentration-time Curve Over the First 12 Weeks Post-dose (AUC0-12W) of OcrelizumabTime frame: Up to 12 weeks
- Maximum Serum Concentration (Cmax) of OcrelizumabTime frame: Up to 12 weeks
Locations
49 sites in 9 countries. Site status is shown where the registry gives one.
Profound Research, LLC
Carlsbad, California
Advanced Neurology of Colorado, LLC
Fort Collins, Colorado
Neurology Associates PA
Maitland, Florida
University of South Florida
Tampa, Florida
Johns Hopkins University School Of Medicine
Baltimore, Maryland
University of Massachusetts Medical School
Worcester, Massachusetts
SUNY Upstate Medical University
Syracuse, New York
Hope Neurology
Knoxville, Tennessee
Swedish Medical Center
Seattle, Washington
Instituto Médico Rivarola IMR
Buenos Aires, Argentina
IME - Instituto Médico Especializado
Buenos Aires, Argentina
Sanatorio del Sur S.A.
San Miguel de Tucumán, Argentina
Centro de Especialidades Neurológicas y Rehabilitación - CENyR
CABA, Buenos Aires, Argentina
Focus CECIC
CABA, CABA / Buenos Aires, Argentina
INECO Neurociencias Orono
Rosario, Santa Fe Province, Argentina
Santa Casa de Misericordia de Salvador
Salvador, Estado de Bahia, Brazil
Instituto de Neurologia de Curitiba
Curitiba, Paraná, Brazil
Cpn - Centro de Pesquisa Neurologica Porto Alegre Ltda
Porto Alegre, Rio Grande do Sul, Brazil
Instituto do Cerebro do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, Brazil
Clinica Neurológica e Neurocirúrgica de Joinville
Joinville, Santa Catarina, Brazil
Centro de Pesquisas Clinicas - CPCLIN
São Paulo, São Paulo, Brazil
Hôpital Guillaume et René Laënnec
Nantes, France
CHU de Nimes - Hopital Universitaire Caremeau
Nîmes, France
Charite - Universitätsmedizin Berlin
Berlin, Germany
St. Josef-Hospital, Klinik für Neurologie
Bochum, Germany
Universitätsklinikum "Carl Gustav Carus", Zentrum für Klinische Neurowissenschaften
Dresden, Germany
Universitätsklinikum Tübingen, Zentrum für Neurologie
Tübingen, Germany
AO.U. Policlinico Riuniti Foggia
Foggia, Apulia, Italy
AOU dell Universita degli Studi della Campania Luigi Vanvitelli Piazza Luigi Miraglia 2
Naples, Campania, Italy
Università degli studi della Campania Luigi Vanvitelli
Naples, Campania, Italy
Policlinico Tor Vergata Dip. Neuroscienze-Clinica Neurologica-UOSD Sclerosi Multipla
Rome, Lazio, Italy
NCL Institute Neuroscience
Rome, Lazio, Italy
Fond. Istituto Neurologico C.Besta
Milan, Lombardy, Italy
IRCCS Istituto Neurologico Neuromed
Pozzilli, Molise, Italy
Inovacion y Desarrollo en ciencias de la salud
Mexico City, Mexico CITY (federal District), Mexico
Neurociencias Prisma, A.C
San Luis Potosí City, San Luis Potosí, Mexico
Neurociencias Estudios Clinicos S.C.
Culiacán, Sinaloa, Mexico
ProNeuro Centrum Medyczne
?ory, Poland
Neurocentrum Bydgoszcz sp z o.o
Bydgoszcz, Poland
Centrum Neurologii Krzysztof Selmaj
Lodz, Poland
Showing 40 of 49 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.